Neuphoria Therapeutics Inc Cash Flow-to-Debt Ratio
Neuphoria Therapeutics Inc cash flow-to-debt ratio. Neuphoria Therapeutics Inc (NEUP) has a Cash Flow-to-Debt Ratio of 0.29x as of June 2026, meaning its operating cash flow of $1.19 Million could theoretically repay 0% of its total liabilities ($4.11 Million) in one year. Check Neuphoria Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Neuphoria Therapeutics Inc (1999–2026)
Cash flow-to-debt ratio of Neuphoria Therapeutics Inc from 1999 to 2026. Historical debt coverage capacity for Neuphoria Therapeutics Inc across 28 annual periods. Check NEUP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Neuphoria Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1999–2026)
Neuphoria Therapeutics Inc cash flow-to-debt ratio by year from 1999 to 2026. Year-by-year debt coverage analysis for Neuphoria Therapeutics Inc. For the full cash flow conversion analysis, see Neuphoria Therapeutics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -3.01x | $-12.35 Billion | $4.11 Billion | ▼ -156.7% |
| 2025 | 5.30x | $77.23 Million | $14.57 Million | ▲ +466.9% |
| 2024 | -1.45x | $-14.68 Million | $10.16 Million | ▲ +30.4% |
| 2023 | -2.08x | $-9.85 Million | $4.74 Million | ▲ +19.9% |
| 2022 | -2.59x | $-21.75 Million | $8.40 Million | ▼ -129.1% |
| 2021 | -1.13x | $-5.66 Million | $5.01 Million | ▼ -531.1% |
| 2020 | -0.18x | $-2.68 Million | $14.97 Million | ▲ +58.6% |
| 2019 | -0.43x | $-10.91 Million | $25.18 Million | ▼ -1.9% |
| 2018 | -0.43x | $-15.02 Million | $35.34 Million | ▼ -889.8% |
| 2017 | -0.04x | $-1.44 Million | $33.52 Million | ▲ +90.5% |
| 2016 | -0.45x | $-15.36 Million | $34.04 Million | ▼ -360.6% |
| 2015 | 0.17x | $4.94 Million | $28.51 Million | ▲ +125.6% |
| 2014 | -0.68x | $-12.91 Million | $19.06 Million | ▲ +27.7% |
| 2013 | -0.94x | $-10.44 Million | $11.14 Million | ▼ -69.4% |
| 2012 | -0.55x | $-2.95 Million | $5.32 Million | ▲ +58.0% |
| 2011 | -1.32x | $-7.89 Million | $6.00 Million | ▲ +2.1% |
| 2010 | -1.35x | $-6.92 Million | $5.14 Million | ▼ -51.3% |
| 2009 | -0.89x | $-4.33 Million | $4.87 Million | ▼ -4.2% |
| 2008 | -0.85x | $-5.54 Million | $6.49 Million | ▼ -0.9% |
| 2007 | -0.85x | $-5.83 Million | $6.89 Million | ▼ -45.0% |
| 2006 | -0.58x | $-3.80 Million | $6.51 Million | ▲ +14.3% |
| 2005 | -0.68x | $-3.31 Million | $4.86 Million | ▲ +3.8% |
| 2004 | -0.71x | $-2.98 Million | $4.22 Million | ▼ -11.1% |
| 2003 | -0.64x | $-2.51 Million | $3.95 Million | ▲ +28.0% |
| 2002 | -0.88x | $-2.91 Million | $3.29 Million | ▲ +88.9% |
| 2001 | -7.96x | $-2.61 Million | $327.78K | ▼ -38.4% |
| 2000 | -5.75x | $-843.87K | $146.83K | ▼ -2657.2% |
| 1999 | -0.21x | $-105.47K | $506.00K | — |